Share：
Share this content in WeChat
X
[Chinese][PDF]78372
• Case Report •
A follow-up case for the patient of lung adenocarcinoma with brain metastases treated with molecule-targeted drugs using quantitative susceptibility mapping
LI Xueping  ZHANG Xin  LI Ming  ZHANG Qinglei  ZHANG Bing 

Cite this article as: Li XP, Zhang X, Li M, et al. A follow-up case for the patient of lung adenocarcinoma with brain metastases treated with molecule-targeted drugs using quantitative susceptibility mapping. Chin J Magn Reson Imaging, 2019, 10(9): 690-692. DOI:10.12015/issn.1674-8034.2019.09.010.


[Keywords] lung neoplasms；neoplasm metastasis；brain neoplasms；targeting preparation；magnetic resonance imaging

LI Xueping Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing 210000, China

ZHANG Xin Department of Radiology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nangjing University Medical School, Nanjing 210000, China

LI Ming Department of Radiology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nangjing University Medical School, Nanjing 210000, China

ZHANG Qinglei Department of Radiology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nangjing University Medical School, Nanjing 210000, China

ZHANG Bing* Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing 210000, China

*Correspondence to: Zhang B, E-mail: zhangbing_nanjing@vip.163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  The National Natural Science Foundation of China No. 81720108022, 91649116
Received  2019-01-26
Accepted  2019-06-29
DOI: 10.12015/issn.1674-8034.2019.09.010
Cite this article as: Li XP, Zhang X, Li M, et al. A follow-up case for the patient of lung adenocarcinoma with brain metastases treated with molecule-targeted drugs using quantitative susceptibility mapping. Chin J Magn Reson Imaging, 2019, 10(9): 690-692. DOI:10.12015/issn.1674-8034.2019.09.010.

[1]
Kobayashi H, Hamasaki M, Morishita T, et al. Clinicopathological and genetic characteristics associated with brain metastases from lung adenocarcinoma and utility as prognostic factors. Oncol Lett, 2018, 16(4): 4243-4252.
[2]
Weber B, Winterdahl M, Memon A, et al. Erlotinib accumulation in brain metastases from non-small cell lung cancer: visualization by positron emission tomography in a patient harboring a mutation in the epidermal growth factor receptor. J Thorac Oncol, 2011, 6(7): 1287-1289.
[3]
Straub S, Laun FB, Emmerich J, et al. Potential of quantitative susceptibility mapping for detection of prostatic calcifications. J Magn Reson Imaging, 2017, 45(3): 889-898.

PREV Comparison of 3D non-contrast enhanced foot MR angiography using steady-state free precession with single and multi-directional FSD modules preparation
NEXT Extraskeletal myxoid chondrosarcoma of carpometacarpal region: a case report
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn